Ameritas Investment Partners, Inc. Neurocrine Biosciences Inc Transaction History

Ameritas Investment Partners, Inc.

$3.05 Billion
Q2 2025

A detailed history of Ameritas Investment Partners, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 19,215 shares of NBIX stock, worth $2.75 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

19,215

Previous 19,617 2.05%

Holding current value

$2.75 Million

Previous $2.17 Million 11.34%

% of portfolio

0.08%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$87.54 - $128.18 $35,191 - $51,528	-402 Reduced 2.05%	19,215 $2.42 Million
Q1 2025 May 12, 2025	SELL	$107.22 - $153.29 $70,979 - $101,477	-662 Reduced 3.26%	19,617 $2.17 Million
Q4 2024 Feb 13, 2025	SELL	$111.62 - $139.44 $48,777 - $60,935	-437 Reduced 2.11%	20,279 $2.77 Million
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $78,945 - $105,520	-689 Reduced 3.22%	20,716 $2.39 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $70,402 - $77,036	-538 Reduced 2.45%	21,405 $2.95 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $32,469 - $35,791	249 Added 1.15%	21,943 $3.03 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $21,956 - $27,481	-207 Reduced 0.95%	21,694 $2.86 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $231,853 - $288,768	-2,466 Reduced 10.12%	21,901 $2.46 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $19,965 - $23,386	-223 Reduced 0.91%	24,367 $2.3 Million
Q1 2023 May 10, 2023	SELL	$94.11 - $123.02 $27,291 - $35,675	-290 Reduced 1.17%	24,590 $2.49 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $30,308 - $36,085	284 Added 1.15%	24,880 $2.97 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $70,771 - $82,905	-769 Reduced 3.03%	24,596 $2.61 Million
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $23,417 - $31,228	294 Added 1.17%	25,365 $2.16 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $41,711 - $47,930	-484 Reduced 1.89%	25,071 $2.41 Million
Q2 2021 Aug 06, 2021	SELL	$89.43 - $102.27 $21,910 - $25,056	-245 Reduced 0.95%	25,555 $2.49 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $2.26 Million - $3.08 Million	25,800 New	25,800 $2.51 Million

Others Institutions Holding NBIX

# of Institutions

683

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Neurocrine Biosciences Inc Transaction History